logo
How heart attack symptoms in women differ from men and why it matters

How heart attack symptoms in women differ from men and why it matters

Heart conditions among Indian women are on the rise—and at an alarming rate. Research published in the Journal of the American College of Cardiology shows that the prevalence of coronary artery disease in Indian women ranges from 3 per cent to 13 per cent, depending on age. Even more concerning, this number has increased by nearly 300 per cent over the past two decades.
The mean age for a heart attack in Indian women is 59 years, significantly lower than the average in developed countries. Meanwhile, the prevalence of heart failure has more than doubled, rising from 1.1 per cent in 2000 to 2.6 per cent in 2015.
These figures make it clear: India needs greater awareness, early screening, and a gender-specific approach to heart health.
How do heart attack symptoms in women differ from those in men?
Heart attack symptoms in women are often subtle and differ from the classic signs seen in men. While men usually report severe chest pain, women are more likely to experience discomfort in the back, jaw, or stomach, along with breathlessness, unusual fatigue, nausea, or dizziness. These symptoms can be mistaken for acidity, weakness, or anxiety, especially in Indian settings where women tend to ignore their health issues. This difference in symptom presentation often leads to late diagnosis and delayed treatment, particularly in younger or post-menopausal women who may not be perceived to be at high cardiac risk.
Why are heart attacks in women often misdiagnosed or missed?
Heart attacks in women are often overlooked because their symptoms tend to differ from the typical patterns seen in men. Many women delay seeking medical help, attributing signs like breathlessness, indigestion, or fatigue to daily stress or household responsibilities. For example, a woman in her forties may present with persistent fatigue and a burning sensation in the chest or upper abdomen, which may be mistaken for acidity. Similarly, a homemaker experiencing jaw pain or dizziness might dismiss it as exhaustion. These situations are increasingly common in urban and semi-urban India, where a lack of awareness about female-specific cardiac symptoms leads to delayed treatment.
What are the unique risk factors and warning signs for women?
Yes, there are several risk factors unique to women that must not be ignored. Hormonal changes due to early menopause, pregnancy-related conditions like high blood pressure or gestational diabetes, and conditions like PCOS increase the likelihood of future heart problems. Mental health issues and chronic stress, especially in urban women juggling work and family, also raise the risk.
Warning signs like sudden tiredness, shortness of breath on routine tasks, chest discomfort, or disturbed sleep should not be taken lightly. Women must be proactive, especially if there's a family history of heart disease or lifestyle-related disorders.
What preventive steps should women take across life stages?
Heart health must be prioritised from an early age. In their twenties and thirties, women should maintain a balanced diet, regular physical activity, and avoid smoking and excessive sugar or salt. In their forties and fifties, routine health check-ups for blood pressure, blood sugar, and cholesterol become crucial, particularly around menopause. Beyond sixty, managing existing conditions like diabetes or thyroid issues is essential, along with staying mentally and physically active.
Which tests help detect heart risks early in women?
To truly assess heart health—especially for women who may have subtle or 'silent' symptoms—more detailed testing is often required:
Echocardiogram (ECHO): Non-invasive ultrasound that checks heart structure and function (₹2,000–₹3,500)
Treadmill Test (TMT): Evaluates how the heart responds to stress or exercise (₹1,500–₹3,000)
Apolipoproteins A and B: Advanced cholesterol markers that offer deeper insights (₹1,000–₹1,800)
Plaque Imaging (Coronary Calcium Scoring/CT Angiography): Detects plaques in arteries before they block (₹4,000–₹10,000)
By combining these tests, doctors can offer a more comprehensive and personalised view of cardiovascular health.
What treatment gaps still exist for women?
Dr Nilesh Gautam, cardiologist at Lilavati Hospital, Mumbai told Business Standard:
'Women often respond differently to heart attack treatments than men, and this significantly affects outcomes. Men typically reach hospitals faster, report classic symptoms like chest pain, and are more likely to receive timely interventions such as angioplasty or clot-dissolving medication. Women, on the other hand, frequently experience subtler symptoms, which leads to delayed hospital visits and often missed diagnoses.'
'Even when treated, women are more likely to experience complications from procedures and side effects from standard cardiac medications like statins or blood thinners. These differences, supported by multiple Indian and global studies, translate into slower recovery, higher post-treatment risk, and poorer long-term outcomes in women. Recognising these distinctions is key to delivering gender-sensitive care in India,' he added.
What is the way forward for women's heart health?
Despite the rising numbers, heart health in women remains under-researched and under-reported. Public awareness campaigns, routine check-ups, and proactive prevention strategies are the need of the hour.
As Dr Gautam suggests, women must be empowered to recognise symptoms early and seek timely care. Heart disease may not discriminate, but our response to it must be more inclusive.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India key healthcare player, a global hub for pharma and medical research: Om Birla
India key healthcare player, a global hub for pharma and medical research: Om Birla

Hans India

time15 minutes ago

  • Hans India

India key healthcare player, a global hub for pharma and medical research: Om Birla

New Delhi: Hailing India's healthcare system for its quality, accessibility, and affordability, Lok Sabha Speaker Om Birla on Saturday called the country a global hub for pharmaceutical and medical research. Speaking at the 7th Annual International Conference of the Innovative Physicians Forum - IPF MEDICON 2025 in the national capital, Birla highlighted India's significant strides in medical infrastructure and service delivery, while remaining cost-effective for all. "The drug manufacturing, vaccine production, and biomedical research within the country shows India is developing as a centre for pharmaceuticals and medical research,' the Speaker said. "India has positioned itself as a key player on the international stage,' he added. He also lauded the progress made in health outreach, digital health technologies, and affordable treatment options, affirming India's commitment to building a robust and equitable healthcare ecosystem. Further, he noted that Indian doctors have earned recognition worldwide, especially during the Covid-19 pandemic. 'Despite limited resources, the dedication, service, and sacrifice of doctors, paramedical staff, and healthcare workers has enabled India to effectively manage the Covid-19 global pandemic and provide successful treatment,' Birla said, calling it 'a true testament to the credibility of India's healthcare system'. Birla added that Indian doctors are enhancing their global reputation by embracing innovation and cutting-edge technologies. 'India's skilled scientists, solid research infrastructure, and focus on innovation are advancing healthcare for both local and global needs,' the Speaker said. He suggested initiatives that promote R&D and collaboration with international institutions to further bolster the country's role in shaping the future of global health. This includes the government's efforts to enhance research, innovation, and free medical treatment for the underprivileged through initiatives like Ayushman Bharat, Birla said. 'Rapid advancements in science and technology must be harnessed to address emerging health challenges and improve patient care,' Birla said, urging for fostering a culture of innovation and investment to help develop 'new treatments, enhancing disease prevention, and strengthening the overall healthcare ecosystem'.

Piyush Goyal slams Siddaramaiah over Covid vaccine remarks, demand public apology
Piyush Goyal slams Siddaramaiah over Covid vaccine remarks, demand public apology

New Indian Express

time20 minutes ago

  • New Indian Express

Piyush Goyal slams Siddaramaiah over Covid vaccine remarks, demand public apology

BENGALURU: Union Minister of Commerce and Industry Piyush Goyal hit out at Chief Minister Siddaramaiah for suggesting that the Covid-19 vaccine may have been linked to heart attack deaths, calling the remarks an insult to Indian scientists, startups, and the country's pharmaceutical strength. He demanded a public apology, stating that Siddaramaiah's comments undermined the people who worked tirelessly during the pandemic. Speaking at IIT Madras Sangam 2025 event on Saturday, Goyal said it was unfortunate that such a statement had come from the CM of a state, in a country known as the 'pharmacy of the world.' He said: 'Our scientists and startups worked day and night, conducted experiments, and built two vaccines when developed nations were struggling. India didn't just protect its own people but also supplied vaccines to 150 countries, giving them free to over 100 countries.' Goyal added: 'Now, when the world is thanking India for saving lives, Siddaramaiah is insulting those efforts. Is he siding with countries that have an agenda against the Indian government? What is he trying to say? He owes a public apology.' Referring to the early days of the Covid-19 pandemic, Goyal pointed out how India faced a severe shortage of PPE kits and vaccines. 'In just days, Indian startups and enterprises developed PPE kits locally and we became the second-largest producers in the world,' he said. 'When we tried to buy vaccines from abroad, we were pushed to the back of the line. Developed countries hoarded expensive vaccines. But India developed its own. Even today, people across the world thank India for saving lives,' he said, adding, 'And yet, the Chief Minister finds this a matter of shame?'

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers
Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers

Hans India

timean hour ago

  • Hans India

Covid vaccine row: Piyush Goyal slams K'taka CM for insulting Indian scientists, drugmakers

New Delhi: Union Commerce and Industry Minister Piyush Goyal on Saturday criticised Karnataka Chief Minister Siddaramaiah for suggesting a link between Covid-19 vaccines developed in India and the sudden deaths. Speaking to the media, on the sidelines of IIT Madras Alumni Association's Sangam 2025 event in Bengaluru, Piyush Goyal praised the Indian scientists for developing Covid vaccine in record time and the pharmaceutical sector for making it cost-effective. 'Fake narratives can't dilute the extraordinary work done by our scientists and the pharma industry in our fight against Covid,' said Goyal. 'Such a big country like India was able to provide 250 crore vaccines for free, because the companies of our country had the strength to make the vaccine at a much lower cost,' he added. His comments come in the wake of Siddaramaiah's recent post on social media platform X on 'the hasty approval and distribution of the Covid vaccine to the public'. The CM linked it to the more than 20 heart attack-related deaths seen in Karnataka's Hassan district in just 40 days. The Union Health Ministry, along with several scientists as well as pharma associations, has denied any link between Covid vaccines and the reported sudden deaths. A joint clarification from the Indian Council of Medical Research (ICMR), All India Institute of Medical Sciences (AIIMS), and the National Centre for Disease Control (NCDC) stated that ongoing surveillance and analyses have not revealed any significant deviation in patterns of cardiac-related deaths since before the pandemic. 'I feel that the Chief Minister here does not disrespect, he insults, and when he insults our scientists, our pharmacy, then I do not know what is the motive behind it?' Goyal said. "Apologise to the Indian scientists and the pharmaceutical sector,' he added. He also asked whether the CM and the Congress are working at the behest of foreign powers. 'Are these the foreign powers whose agenda they are running here, are the foreign powers who want to lure India's pharmacy, are they troubled by India's economic progress and development,' Goyal said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store